# Page 1
Revised administrative approval for procurement of Remdesivir 100mg for COVID-19 patients under the Epidemic Control Programme.
The Government of Maharashtra
the Department of Public Health
Government Supplementary Letter No: Supplementary Demand-2020/ PR No.91/ Health-8
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
Date of Birth: May 5, 2021
Government Resolution No. Supplementary Demands-2020/ PR No.91/ Arogya-8 dated 26.3.2021 2) Letter No. Remdesivir 100 mg/ day MA/ 6318-21/ dated 20.4.2021
Government Supplementary Letter: Due to the prevalence of the Covid-19 epidemic in the state, administrative approval has been given under No. 1 in Vacha for the purchase of (100 mg) Remdesivir for the affected patients. The rate of Remdesivir (100 mg) in the column Approx Rate at A-Cr-1 in the statement should be read as' Rs 1468/- instead of Rs 668.52/-.
Due to the outbreak of Covid-19 in the state, there is an urgent need for medicines. The Review High Powered Committee under para 2.8 of 01.12.2016 in its meeting dated 30.4.2021 has given ex-post facto approval for procurement of (inj Remdisivir 100 mg) by relaxing the conditions of the procurement policy.
30/2013/ Regulations, Part-II dated 17.04.2015 in Annexure to the Financial Powers Rules, 1978, Part-I, Sub-Division II A.No.4, Rule No. The proposal is being approved as per the powers conferred on the administrative department under Section 7.
# Page 2